Reagent for extracting RNA or DNA virus in body fluid
A technology of reagents and body fluids, applied in the field of biochemistry, can solve the problems of cumbersome steps, low efficiency, and low extraction efficiency, and achieve the effects of reducing protein impurities, reducing co-precipitation, and improving utilization
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
example 1
[0021] The reagent composition of the invention: 5.4 mol guanidine isothiocyanate, 2 mol guanidine hydrochloride, 25 mmol sodium citrate, 20 ml β-mercaptoethanol, 7 g sodium lauryl sarcosinate, 2 mol urea, 64 mg glycogen, and the rest is water.
[0022] The preparation of the reagent of the present invention: take guanidine isothiocyanate, guanidine hydrochloride, sodium citrate 2, β-mercaptoethanol, sodium lauryl sarcosinate, urea and glycogen and mix them with DEPC-treated water to dissolve and Quantify to 1L, then filter with 0.45μm membrane.
[0023] Extraction of viral RNA:
[0024] (1) Material: Dilute the SIV virus standard (international standard SIV virus particle standard, gifted by Professor Lu Wei, University of Paris Fifth, France) with monkey plasma to 6 concentrations, respectively: 0.5×10 7 copies / ml, 0.5×10 6 copies / ml, 0.5×10 5 copies / ml, 0.5×10 4 copies / ml, 0.5×10 3 copies / ml, 0.5×10 2 copies / ml, 12 parallel extraction experiments for each concentration. At the ...
example 2
[0052] The reagent composition of the present invention is 5.4 mol of guanidine isothiocyanate, 2 mol of guanidine hydrochloride, 25 mmol of sodium citrate, 20 ml of β-mercaptoethanol, 7 g of sodium lauryl sarcosinate, 2 mol of urea, 64 mg of glycogen, and the rest is water.
[0053] The preparation of the reagent of the present invention: Take guanidine isothiocyanate, guanidine hydrochloride, sodium citrate, β-mercaptoethanol, sodium lauryl sarcosinate, urea and glycogen and mix them with DEPC-treated water to dissolve and quantify To 1L, then filter with 0.45μm filter membrane.
[0054] Experimental materials: serum samples of patients with HBVDNA quantitative copy number above 1e9 tested in the hospital.
[0055] Dilute HBVDNA patient serum samples with cell culture newborn calf serum, and dilute to: 5e8 copies / ml, 5e7 copies / ml, 5e6 copies / ml, 5e5 copies / ml, 5e4 copies / ml, 5e3 copies / ml, 5e2 copies / Ml, 5e1 copies / ml, 3 replicate holes for each concentration, and 1 hole of ne...
example 3
[0069] The reagent composition of the present invention: 4mol of guanidine isothiocyanate, 1mol of guanidine hydrochloride, 20mmol of sodium citrate, 10ml of β-mercaptoethanol, 5g of sodium lauryl sarcosinate, 1.5mol of urea, 60mg of glycogen, and water as the balance.
[0070] The preparation of the reagent of the present invention: take guanidine isothiocyanate, guanidine hydrochloride, sodium citrate, β-mercaptoethanol, sodium lauryl sarcosinate, urea and glycogen, and mix them with DEPC-treated water to dissolve and quantify To 1L, then filter with 0.45μm filter membrane.
[0071] Experimental materials: serum samples of patients with HBVDNA quantitative copy number above 1e9 tested in the hospital.
[0072] Dilute HBVDNA patient serum samples with cell culture newborn calf serum, and dilute to: 5e8 copies / ml, 5e7 copies / ml, 5e6 copies / ml, 5e5 copies / ml, 5e4 copies / ml, 5e3 copies / ml, 5e2 copies / Ml, 5e1 copies / ml, 3 replicate holes for each concentration, and 1 hole of newborn...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com